Evidence map›Paper›PMID 19474272›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2009

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.

Christiane Drechsler, Vera Krane, Diana C Grootendorst, Eberhard Ritz, Karl Winkler, Winfried März, Friedo Dekker, Christoph Wanner, German Diabetes and Dialysis Study Investigators

Open access · hybridAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. HMG CoA reductase inhibitors (statins) for dialysis patients.The Cochrane database of systematic reviews · 2013 · on this map
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. The Obesity Paradox and the Role of Inflammation.Journal of the American Society of Nephrology : JASN · 2016
    Article
  9. Observational
  10. Article
  11. Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Observational
  12. Article
  13. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2011
    Review
  14. Article
  15. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2010
    Article
  16. Does PTH offer additive value to ALP measurement in assessing CKD-MBD?Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Christiane DrechslerDivision of Nephrology, Department of Medicine, University of Würzburg, Germany. drechsler_c@medizin.uni-wuerzburg.de
Vera Krane
Diana C Grootendorst
Eberhard Ritz
Karl Winkler
Winfried März
Friedo Dekker
Christoph Wanner
German Diabetes and Dialysis Study Investigators
University of Würzburg · DELeiden University Medical Center · NLHeidelberg University · DESynlab (Germany) · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association between parathyroid hormone (PTH) level and mortality in dialysis patients is controversial. We hypothesized that wasting, a common condition potentially related to adynamic bone disease, modifies the association of PTH with mortality and cardiovascular events (CVE), respectively.

methodsWe analysed data from 1255 diabetic haemodialysis patients, participating in the German Diabetes and Dialysis Study between 1998 and 2004. The patients were stratified by the presence or absence of wasting (albumin <or=3.8 versus albumin >3.8 g/dL; BMI <or=23 versus BMI >23 kg/m(2)). Using Cox regression analyses, we calculated the risks of (1) all-cause mortality and (2) CVE according to baseline PTH levels. All analyses were adjusted for age, sex, atorvastatin treatment, duration of dialysis, comorbidity, HbA1c, phosphate, calcium, blood pressure, haemoglobin and C-reactive protein.

resultsPatients had a mean age of 66 +/- 8 years, and 54% were male. Among patients without wasting (albumin >3.8 g/dL, n = 586), the risks of death and CVE during 4 years of follow-up significantly increased by 23% and 20% per unit increase in logPTH. Patients in the highest PTH tertile had a 74% higher risk of death (HR(adj) 1.74, 95% CI 1.27-2.40) and a 49% higher risk of CVE (HR(adj) 1.49, 95% CI 1.05-2.11) compared to patients in the lowest PTH tertile. In contrast, no effect was found in patients with wasting. Accordingly, additional analyses in strata of BMI showed that PTH significantly impacted on death and CVE [HR(logPTH)(adj) 1.15 and 1.14, respectively] only in patients without, but not in patients with, wasting.

conclusionsWasting modifies the association of PTH with adverse outcomes in diabetic dialysis patients. High PTH levels are of concern in the patients without wasting, while the effect of PTH on mortality is nullified in the patients with wasting.

Indexed as

AgedCardiovascular DiseasesFemaleHumansMaleParathyroid HormoneRenal DialysisWasting SyndromeParathyroid Hormone

Identifiers

PMID19474272
PMCPMC2747498
OpenAlexW2123786809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.